{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:05:51Z","timestamp":1791133551174,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T00:00:00Z","timestamp":1210291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00259-008-0788-z","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T11:40:31Z","timestamp":1210246831000},"page":"1766-1774","source":"Crossref","is-referenced-by-count":238,"title":["Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET\u2013CT: a comparative study"],"prefix":"10.1007","volume":"35","author":[{"given":"Mohsen","family":"Beheshti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Vali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Waldenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Fitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Loidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Broinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Stoiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignac","family":"Foglman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Langsteger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,5,9]]},"reference":[{"key":"788_CR1","first-page":"1","volume-title":"Prostate cancer: can we reduce mortality while preserving the quality of life?","author":"D Blum","year":"1995","unstructured":"Blum D. Prostate cancer: can we reduce mortality while preserving the quality of life? Washington, DC: US Department of Health and Human Services; 1995. p. 1."},{"key":"788_CR2","unstructured":"Davidson P, Gabbay J. Should mass screening for prostate cancer be introduced at the national level? WHO Regional Office for Europe\u2019s Health Evidence Network Report (HEN), May 2004."},{"issue":"6 Pt 1","key":"788_CR3","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/01.ju.0000123981.03084.06","volume":"171","author":"S Abuzallouf","year":"2004","unstructured":"Abuzallouf S, Dayes I, Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 2004;171(6 Pt 1):2122\u20137.","journal-title":"J Urol"},{"issue":"2","key":"788_CR4","first-page":"287","volume":"47","author":"E Even-Sapir","year":"2006","unstructured":"Even-Sapir E, Metser U, Mishani E, Lievshitz G, Lerman H, Leibovitch I. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT. J Nucl Med 2006;47(2):287\u201397.","journal-title":"J Nucl Med"},{"issue":"9","key":"788_CR5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s002590050287","volume":"25","author":"AF Jacobson","year":"1998","unstructured":"Jacobson AF, Fogelman I. Bone scanning in clinical oncology: does it have a future? Eur J Nucl Med 1998;25(9):1219\u201323.","journal-title":"Eur J Nucl Med"},{"issue":"10","key":"788_CR6","first-page":"1623","volume":"40","author":"H Schirrmeister","year":"1999","unstructured":"Schirrmeister H, Guhlmann A, Elsner K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med 1999;40(10):1623\u201329.","journal-title":"J Nucl Med"},{"issue":"12","key":"788_CR7","first-page":"1800","volume":"42","author":"H Schirrmeister","year":"2001","unstructured":"Schirrmeister H, Glatting G, Hetzel J, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001;42(12):1800\u20134.","journal-title":"J Nucl Med"},{"issue":"1","key":"788_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/snuc.2001.18746","volume":"31","author":"GJ Cook","year":"2001","unstructured":"Cook GJ, Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med 2001;31(1):50\u20131.","journal-title":"Semin Nucl Med"},{"issue":"12 Suppl","key":"788_CR9","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/1097-0142(20000615)88:12+<2927::AID-CNCR8>3.0.CO;2-V","volume":"88","author":"GJ Cook","year":"2000","unstructured":"Cook GJ, Fogelman I. The role of positron emission tomography in the management of bone metastases. Cancer 2000;88(12 Suppl):2927\u201333.","journal-title":"Cancer"},{"issue":"6","key":"788_CR10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","volume":"37","author":"E Even-Sapir","year":"2007","unstructured":"Even-Sapir E, Mishani E, Flusser G, Metser U. 18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography. Semin Nucl Med 2007;37(6):462\u201369.","journal-title":"Semin Nucl Med"},{"issue":"12","key":"788_CR11","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","volume":"33","author":"M Cimitan","year":"2006","unstructured":"Cimitan M, Bortolus R, Morassut S, et al. [(18)F]fluorocholine PET\/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging 2006;33(12):1387\u201398.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"788_CR12","first-page":"262","volume":"47","author":"SA Kwee","year":"2006","unstructured":"Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med 2006;47(2):262\u20139.","journal-title":"J Nucl Med"},{"issue":"8","key":"788_CR13","first-page":"1249","volume":"47","author":"SN Reske","year":"2006","unstructured":"Reske SN, Blumstein NM, Neumaier B, et al. Imaging prostate cancer with 11C-choline PET\/CT. J Nucl Med 2006;47(8):1249\u201354.","journal-title":"J Nucl Med"},{"issue":"7","key":"788_CR14","first-page":"1233","volume":"45","author":"MA Seltzer","year":"2004","unstructured":"Seltzer MA, Jahan SA, Sparks R, et al. Radiation dose estimates in humans for (11)C-acetate whole-body PET. J Nucl Med 2004;45(7):1233\u20136.","journal-title":"J Nucl Med"},{"issue":"11","key":"788_CR15","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.bmc.2004.03.051","volume":"12","author":"QH Zheng","year":"2004","unstructured":"Zheng QH, Gardner TA, Raikwar S, et al. [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem 2004;12(11):2887\u201393.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"788_CR16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semnuclmed.2004.06.004","volume":"34","author":"H Schoder","year":"2004","unstructured":"Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34(4):274\u201392.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"788_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.semnuclmed.2004.11.005","volume":"35","author":"I Fogelman","year":"2005","unstructured":"Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35(2):135\u201342.","journal-title":"Semin Nucl Med"},{"issue":"8","key":"788_CR18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.1999.17.8.2381","volume":"17","author":"H Schirrmeister","year":"1999","unstructured":"Schirrmeister H, Guhlmann A, Kotzerke J, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999;17(8):2381\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"788_CR19","first-page":"272","volume":"45","author":"E Even-Sapir","year":"2004","unstructured":"Even-Sapir E, Metser U, Flusser G, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET\/CT and comparison between 18F-fluoride PET and 18F-fluoride PET\/CT. J Nucl Med 2004;45(2):272\u201378.","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"788_CR20","first-page":"S122","volume":"34","author":"M Beheshti","year":"2007","unstructured":"Beheshti M, Vali R, Fitz F, et al. Influence of hormone therapy in assessment of bone metastases in prostate cancer by means of F-18 choline PET\/CT. Eur J Nuclear Med Mol Imaging 2007;34(Suppl 2):S122.","journal-title":"Eur J Nuclear Med Mol Imaging"},{"issue":"Suppl","key":"788_CR21","first-page":"342P","volume":"30","author":"D Vassiliev","year":"2003","unstructured":"Vassiliev D, Krasikova R, Kutznetsova O, Federova O, Nader M. Simple HPLC method for the detection of N,N-dimethylaminoethanol in the preparation of [N-methyl-11C] choline. Eur J Nucl Med Mol Imaging 2003;30(Suppl):342P.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"788_CR22","first-page":"136P","volume":"48","author":"MW Nader","year":"2007","unstructured":"Nader MW, Schubert M, Becker DW. Design and validation of a semi-automated sodium[18F]fluoride formulation system. J Nucl Med 2007;48(Suppl 2):136P.","journal-title":"J Nucl Med"},{"issue":"8","key":"788_CR23","first-page":"1356","volume":"46","author":"E Even-Sapir","year":"2005","unstructured":"Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 2005;46(8):1356\u201367.","journal-title":"J Nucl Med"},{"issue":"2","key":"788_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s002560050340","volume":"27","author":"M Petren-Mallmin","year":"1998","unstructured":"Petren-Mallmin M, Andreasson I, Ljunggren O, et al. Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT. Skelet Radiol 1998;27(2):72\u20136.","journal-title":"Skelet Radiol"},{"issue":"1","key":"788_CR25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11307-005-0023-2","volume":"8","author":"M Heinisch","year":"2006","unstructured":"Heinisch M, Dirisamer A, Loidl W, et al. Positron emission tomography\/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5\u00a0ng\/ml. Mol Imaging Biol 2006;8(1):43\u20138.","journal-title":"Mol Imaging Biol"},{"issue":"Suppl 2","key":"788_CR26","first-page":"208","volume":"33","author":"M Beheshti","year":"2006","unstructured":"Beheshti M, Haim S, Nader M, et al. Assessment of bone metastases in patients with prostate cancer by dual-phase F-18 fluor choline PET\/CT. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):208.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"788_CR27","first-page":"209","volume":"33","author":"W Langsteger","year":"2006","unstructured":"Langsteger W, Beheshti M, Nader M, et al. Evaluation of lymph node and bone metastases with fluor choline (FCH) PET\u2013CT in the follow-up of prostate cancer patients. Eur J Nucl Med Mol Imaging 2006;33(Suppl 2):209.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"788_CR28","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1002\/jbmr.5650051313","volume":"5","author":"S Bang","year":"1990","unstructured":"Bang S, Baud CA. Topographical distribution of fluoride in iliac bone of a fluoride-treated osteoporotic patient. J Bone Miner Res 1990;5(Suppl 1):S87\u20139.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"788_CR29","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","volume":"16","author":"GJ Cook","year":"1998","unstructured":"Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998;16(10):3375\u20139.","journal-title":"J Clin Oncol"},{"key":"788_CR30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00003086-198609000-00005","volume":"210","author":"CS Galasko","year":"1986","unstructured":"Galasko CS. Skeletal metastases. Clin Orthop Relat Res 1986;210:18\u201330.","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"788_CR31","first-page":"1625","volume":"36","author":"AC Clavo","year":"1995","unstructured":"Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 1995;36(9):1625\u201332.","journal-title":"J Nucl Med"},{"issue":"5","key":"788_CR32","first-page":"633","volume":"33","author":"RA Hawkins","year":"1992","unstructured":"Hawkins RA, Choi Y, Huang SC, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 1992;33(5):633\u201342.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0788-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-008-0788-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0788-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:34:50Z","timestamp":1708907690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-008-0788-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,9]]},"references-count":32,"aliases":["10.1007\/s00259-008-0817-y"],"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s00259-008-0788-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,9]]}}}